Targeting death and decoy receptors of the tumour-necrosis factor superfamily
Top Cited Papers
- 1 June 2002
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 2 (6) , 420-430
- https://doi.org/10.1038/nrc821
Abstract
No abstract availableKeywords
This publication has 131 references indexed in Scilit:
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001
- Genomic Organization and Transcriptional Regulation of Human Apo2/TRAIL GeneBiochemical and Biophysical Research Communications, 2000
- TNF Registered in Europe: Does TNF Get a Second Chance?Journal of Immunotherapy, 2000
- Locoregional Apo2L/TRAIL Eradicates Intracranial Human Malignant Glioma Xenografts in Athymic Mice in the Absence of NeurotoxicityBiochemical and Biophysical Research Communications, 1999
- Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor–related Cytokine, TRAILThe Journal of Experimental Medicine, 1999
- APO2 ligand: a novel lethal weapon against malignant glioma?FEBS Letters, 1998
- TRAIL/Apo-2-ligand-induced apoptosis in human T cellsEuropean Journal of Immunology, 1998
- Apoptosis by Death FactorCell, 1997
- Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κBCurrent Biology, 1996
- Two TNF receptorsImmunology Today, 1992